drugset / Trial / NCT00006480
Biological Therapy and Gene Therapy in Treating Children With Recurrent or Refractory Neuroblastoma
Treatment
Summary
RATIONALE: Biological therapies use different ways to stimulate the immune system and stop cancer cell from growing. Inserting genetic material made in the laboratory into a person's blood cells may make the body build an immune response to kill tumor cells. PURPOSE: Phase I trial to study the effectiveness of biological therapy and gene therapy in treating children who have recurrent or refractory neuroblastoma.
Timeline
- Start
- 2000-05
- Primary completion
- —
- Completion
- 2005-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | aldesleukin | Protein / enzyme biologic | — | Subcutaneous |
| Subject | therapeutic autologous lymphocytes | Cell therapy | — | Intravenous |
| Background | Ganciclovir | Small molecule | — | Intravenous |